Literature DB >> 22128384

Meningococcal vaccines: WHO position paper, November 2011.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22128384

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  65 in total

Review 1.  Vaccination of adolescents with chronic medical conditions: Special considerations and strategies for enhancing uptake.

Authors:  Annika M Hofstetter; Philip LaRussa; Susan L Rosenthal
Journal:  Hum Vaccin Immunother       Date:  2015-07-25       Impact factor: 3.452

2.  Serogroup-specific interaction of Neisseria meningitidis capsular polysaccharide with host cell microtubules and effects on tubulin polymerization.

Authors:  Adelfia Talà; Laura Cogli; Mario De Stefano; Marcella Cammarota; Maria Rita Spinosa; Cecilia Bucci; Pietro Alifano
Journal:  Infect Immun       Date:  2013-10-28       Impact factor: 3.441

Review 3.  Vaccine-preventable infections in Systemic Lupus Erythematosus.

Authors:  Giuseppe Murdaca; Andrea Orsi; Francesca Spanò; Valeria Faccio; Francesco Puppo; Paolo Durando; Giancarlo Icardi; Filippo Ansaldi
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

Review 4.  Review of meningococcal vaccines with updates on immunization in adults.

Authors:  Yorgo C Zahlanie; Moza M Hammadi; Soha T Ghanem; Ghassan S Dbaibo
Journal:  Hum Vaccin Immunother       Date:  2014-02-05       Impact factor: 3.452

5.  Epidemiology of infant meningococcal disease in the United States, 2006-2012.

Authors:  Jessica R MacNeil; Nancy Bennett; Monica M Farley; Lee H Harrison; Ruth Lynfield; Megin Nichols; Sue Petit; Arthur Reingold; William Schaffner; Ann Thomas; Tracy Pondo; Leonard W Mayer; Thomas A Clark; Amanda C Cohn
Journal:  Pediatrics       Date:  2015-01-12       Impact factor: 7.124

6.  Neisseria lactamica antigens complexed with a novel cationic adjuvant.

Authors:  Emanuelle B Gaspar; Andreza S Rosetti; Nilton Lincopan; Elizabeth De Gaspari
Journal:  Hum Vaccin Immunother       Date:  2013-01-07       Impact factor: 3.452

7.  An outbreak of serogroup C (ST-11) meningococcal disease in Tijuana, Mexico.

Authors:  Enrique Chacon-Cruz; Luz Elena Espinosa-De Los Monteros; Samuel Navarro-Alvarez; Jose Luis Aranda-Lozano; Maria Luisa Volker-Soberanes; Rosa Maria Rivas-Landeros; Ariadna Annete Alvelais-Arzamendi; Julio Alberto Vazquez
Journal:  Ther Adv Vaccines       Date:  2014-05

Review 8.  Meningococcal B vaccination: real-world experience and future perspectives.

Authors:  Parvanè Kuhdari; Armando Stefanati; Silvia Lupi; Nicoletta Valente; Giovanni Gabutti
Journal:  Pathog Glob Health       Date:  2016-06-16       Impact factor: 2.894

9.  Immunogenicity and safety of investigational vaccine formulations against meningococcal serogroups A, B, C, W, and Y in healthy adolescents.

Authors:  Xavier Saez-Llorens; Diana Catalina Aguilera Vaca; Katia Abarca; Emmanuelle Maho; Maria Gabriela Graña; Esther Heijnen; Igor Smolenov; Peter M Dull
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 10.  Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines.

Authors:  Rodolfo Villena; Marco Aurelio P Safadi; María Teresa Valenzuela; Juan P Torres; Adam Finn; Miguel O'Ryan
Journal:  Hum Vaccin Immunother       Date:  2018-04-30       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.